1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics 2020 - China (p10)

Biotechnology Analysis & Statistics 2020 - China (p10)

271-300 of about 400 reports

T-Cell Immunotherapy Market (3rd Edition), 2018-2030

  • $ 3499
  • April 2018
  • 850 pages

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide, accounting for 0.6 million deaths in 2017 in the US alone. The World Health Organization states that the number of new cance ...

  • Biotechnology
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • China

BeyondSpring Pharmaceuticals Inc (BYSI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • April 2018
  • 36 pages

Summary BeyondSpring Pharmaceuticals Inc (BeyondSpring) is a clinical stage biopharmaceutical company that offers development of innovative immune-oncology cancer therapies.The company’s lead compound, ...

  • Biotechnology
  • Chemotherapy
  • Pharmaceutical
  • China
  • BeyondSpring Pharmaceuticals Inc.

Biosilu Healthcare AG (1YA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • April 2018
  • 18 pages

Summary Biosilu Healthcare AG (Biosilu Healthcare), formerly Amp Biosimilars AG is a life science company that develops and commercializes biopharmaceuticals.The company’s product pipeline comprises ...

  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • China
  • Deals & Alliance

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H1 2018

  • $ 3500
  • February 2018
  • 70 pages

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H1 2018 Summary Caspase 9 (Apoptotic Protease ...

  • Biotechnology
  • Chemotherapy
  • Pharmaceutical
  • China
  • Product Initiative

Caspase 8 - Pipeline Review, H1 2018

  • $ 3500
  • January 2018
  • 61 pages

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog ...

  • Biotechnology
  • Chemotherapy
  • Therapy
  • China
  • Conatus Pharmaceuticals Inc.

China In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

  • $ 5995
  • December 2017
  • 547 pages

China In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture Su ...

  • Biotechnology
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • China
  • East Asia

Asia-Pacific Genetic Testing Market Outlook to 2024

  • $ 5995
  • December 2017
  • 85 pages

Asia-Pacific Genetic Testing Market Outlook to 2024 Summary GlobalData’s new report, Asia-Pacific Genetic Testing Market Outlook to 2024, provides key market data on the Asia-Pacific Genetic Testing ...

  • Biotech Diagnostics
  • Biotechnology
  • Diagnostics
  • Genetic Testing
  • China

BRIC Infectious Diagnostics Market Outlook to 2024

  • $ 5995
  • December 2017
  • 504 pages

BRIC Infectious Diagnostics Market Outlook to 2024 Summary GlobalData’s new report, BRIC Infectious Diagnostics Market Outlook to 2024, provides key market data on the BRIC Infectious Diagnostics market. ...

  • Biotechnology
  • Diagnostics
  • Infectious Disease
  • Molecular Diagnostics
  • China

BRIC Genetic Testing Market Outlook to 2024

  • $ 5995
  • December 2017
  • 53 pages

BRIC Genetic Testing Market Outlook to 2024 Summary GlobalData’s new report, BRIC Genetic Testing Market Outlook to 2024, provides key market data on the BRIC Genetic Testing market. The report provides ...

  • Biotech Diagnostics
  • Biotechnology
  • Diagnostics
  • Genetic Testing
  • China

Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2017
  • 23 pages

Summary Chinese Academy of Sciences (CAS) is a research institute that provides advisory and appraisal services on issues arising from the national economy, social development, and science and technology ...

  • Biotechnology
  • Healthcare
  • Pharmaceutical
  • China
  • Deals & Alliance

Institut Pasteur - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2017
  • 33 pages

Summary Institut Pasteur is a non-profit foundation that provides research, health services and education. The institute offers research in the areas of biology, genomes and genetics, immunology, infection ...

  • Biotechnology
  • Healthcare
  • Pharmaceutical
  • China
  • Deals & Alliance

China Infectious Diagnostics Market Outlook to 2024

  • $ 4995
  • November 2017
  • 144 pages

China Infectious Diagnostics Market Outlook to 2024 Summary GlobalData’s new report, China Infectious Diagnostics Market Outlook to 2024, provides key market data on the China Infectious Diagnostics ...

  • Biotechnology
  • China
  • Alere Inc.
  • DiaSorin S.p.A.
  • QIAGEN N.V.

Rui Kang Pharmaceutical Group Investments Ltd (8037) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2017
  • 24 pages

Summary Rui Kang Pharmaceutical Group Investments Ltd (Rui Kang Pharmaceutical), formerly Longlife Group Holdings Ltd is an investment holding company that offers pharmaceutical products and services. ...

  • Biotechnology
  • Pharmaceutical
  • China
  • Company
  • Rui Kang Pharmaceutical Group Investments Limited

MedAnnex Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2017
  • 16 pages

Summary MedAnnex Ltd (MedAnnex) is a biopharmaceutical company that offers monoclonal antibodies. The company offers development of new treatments for autoimmune diseases. It offers annexuzlimab, a specific ...

  • Medical Biotechnology
  • China
  • United Kingdom
  • Deals & Alliance
  • MedAnnex Ltd

China Histology And Cytology Market Outlook to 2024

  • $ 4995
  • November 2017
  • 22 pages

China Histology And Cytology Market Outlook to 2024 Summary GlobalData’s new report, China Histology And Cytology Market Outlook to 2024, provides key market data on the China Histology And Cytology ...

  • Biotechnology
  • Diagnostics
  • China
  • Company
  • Thermo Fisher Scientific, Inc.

China Genetic Testing Market Outlook to 2024

  • $ 4995
  • November 2017
  • 35 pages

China Genetic Testing Market Outlook to 2024 Summary GlobalData’s new report, China Genetic Testing Market Outlook to 2024, provides key market data on the China Genetic Testing market. The report provides ...

  • Biotechnology
  • Genetic Testing
  • China
  • Market Size
  • Illumina, Inc.

Biosensors International Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2017
  • 20 pages

Summary Biosensors International Group Ltd (Biosensors) is a medical devices company. It develops, manufactures and markets medical devices. The company products find application in Interventional cardiology ...

  • Biotechnology
  • Nanobiotechnology
  • China
  • M&A
  • Biosensors International Group, Ltd.

PHARMA LEADER SERIES: 25 TOP BIOSIMILAR DRUG MANUFACTURERS 2017-2027

  • $ 4468
  • August 2017
  • 233 pages

And Other Rising Companies – a Market Report Assessing Developers and Producers of Competitor Biologics Report Details Who Are the Leaders in the Emerging Biosimilar Drugs Market? Visiongain’s New ...

  • Biosimilar
  • Biotechnology
  • Medical Biotechnology
  • China
  • Company

China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)

  • $ 1200
  • August 2017
  • 105 pages

China molecular diagnostics market is expected to be more than USD 1.5 Billion by the year 2022. As a part of the evolution of medicine in China; en route for targeted therapy and recognizing the revenue ...

  • Biotechnology
  • Diagnostics
  • Molecular Diagnostics
  • China
  • East Asia

China Bioprocess Instruments Market Size, Forecast And Trend Analysis, 2014 - 2024

  • $ 1950
  • August 2017
  • 35 pages

China Bioprocess Instruments Market Size and Forecast, By Type (Cell Expansion, Flow Cytometry, Biologics Safety Testing, Cell Line Development, Tangential Flow Filtration, Cell Counters, Virus Filtration, ...

  • Biotechnology
  • Medical Biotechnology
  • China
  • Forecast

Global Cancer Gene Therapy Market 2017-2021

  • $ 2500
  • August 2017
  • 85 pages

About Cancer Gene Therapy Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual’s ...

  • Biotechnology
  • Cancer
  • Gene Therapy
  • Therapy
  • China

MEDITE Cancer Diagnostics Inc (MDIT) - Product Pipeline Analysis, 2017 Update

  • $ 750
  • July 2017
  • 37 pages

Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, ...

  • Biotechnology
  • Cancer
  • Cancer Diagnostics
  • Diagnostics
  • China

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • June 2017
  • 416 pages

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

  • Biotechnology
  • Breast Cancer
  • Cancer
  • Therapy
  • China

3SBio Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • June 2017
  • 63 pages

3SBio Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s 3SBio Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report ...

  • Biotechnology
  • Pharmaceutical
  • China
  • M&A
  • 3SBio Inc.

China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022

  • $ 1390
  • June 2017
  • 100 pages

China In-Vitro Diagnostics (IVD) market is likely to more than triple by 2022 from its current level in 2016. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, ...

  • Biotechnology
  • China
  • Abbott Laboratories, Inc.
  • Mindray Medical International Limited
  • Roche Group

Market Research on Stem Cell in China 2017-2022

  • $ 3500
  • May 2017
  • 47 pages

At present, there are nearly a hundred enterprises working in research and development of stem cell technology, construction of stem cell banks and application of related products. In 2016, industrial ...

  • Biotechnology
  • China

China Interferon Industry Report, 2016-2021

  • $ 2300
  • April 2017
  • 82 pages

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-? is mainly suitable for curing hepatitis B and hepatitis ...

  • Biotechnology
  • Interferon
  • Medical Biotechnology
  • China
  • Market Size

China Biopesticide Market Forecast 2017-2025

  • $ 718
  • April 2017
  • 45 pages

KEY FINDINGS The China biopesticides market generated revenue of $220 Million in 2016 and is anticipated to contribute $1363 Million by 2025, growing at a CAGR of 22.4%. Increasing demand for quality food ...

  • Agricultural Biotechnology
  • Agricultural Technology
  • Biotechnology
  • China
  • Demand

Market Research of Microalgae DHA in China

  • $ 9504
  • April 2017
  • 76 pages

Microalgae DHA has been developing in China for more than 10 years. With a growing concern for health by Chinese people, microalgae DHA as a healthful food additive has become more and more popular in ...

  • Biotechnology
  • China
  • Demand
  • Supply
  • Trade

Market Research on Stalk Fired Machine in China 2017-2022

  • $ 3500
  • April 2017
  • 54 pages

Machines of burning biomass pellets started to be used in 80s of the 20th century, but it took some market shares in the later period of 90s in Switzerland, Denmark and Austria. In China, biomass fuels ...

  • Industrial Biotechnology
  • China
  • Demand
  • Supply
  • Trade

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on